GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development

Authors
Knudsen, LB Agerso, H Bjenning, C Bregenholt, S Carr, RD Godtfredsen, C Holst, JJ Huusfeldt, PO Larsen, MO Larsen, PJ Nielsen, PF Ribel, U Rolin, B Romer, J Sturis, J Wilken, M Kristensen, P
Citation
Lb. Knudsen et al., GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development, DRUG FUTURE, 26(7), 2001, pp. 677-685
Citations number
92
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUGS OF THE FUTURE
ISSN journal
03778282 → ACNP
Volume
26
Issue
7
Year of publication
2001
Pages
677 - 685
Database
ISI
SICI code
0377-8282(200107)26:7<677:GDANCF>2.0.ZU;2-2